TrialMediators of inflammation2022

Overall Structural Alteration of Gut Microbiota and Relationships with Risk Factors in Patients with Metabolic Syndrome Treated with Inulin Alone and with Other Agents: An Open-Label Pilot Study.

Ruiping Tian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.